However, the sensitivity and specificity of these traditional biomarkers (CEA and CA19-9) remain low for CRC, highlighting the urgent need to explore novel biomarkers to aid diagnosis [26]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.